Recombinant adenoviruses for in vivo expression of antibody fragments.
Kontermann
Roland E
RE
Vectron Therapeutics AG, Marburg, Germany.
Korn
Tina
T
Jérôme
Valérie
V
D000256:Adenoviridae / Q000235:genetics* / Q000302:isolation & purification; D000818:Animals; D018033:Antibodies, Bispecific / Q000096:biosynthesis* / Q000276:immunology; D017931:DNA Primers / Q000737:chemistry; D004274:DNA, Recombinant / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D015870:Gene Expression; D018014:Gene Transfer Techniques; D005818:Genetic Engineering / Q000379:methods; D005822:Genetic Vectors / Q000096:biosynthesis* / Q000302:isolation & purification*; D006801:Humans; D007128:Immunoglobulin Fragments / Q000009:adverse effects / Q000276:immunology / Q000494:pharmacology; D008099:Liver / Q000276:immunology / Q000378:metabolism*; D051379:Mice; D016513:Mice, SCID; D016133:Polymerase Chain Reaction / Q000379:methods*
D018033:Antibodies, Bispecific; D017931:DNA Primers; D004274:DNA, Recombinant; D007128:Immunoglobulin Fragments